Governance Regeneron Pharmaceuticals, Inc.

REGN

US75886F1075

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 01:30:00 11/06/2026 am IST			After hours 05:30:00 am
601.65 ^USD	-2.36%		606.35	+0.78%

10/06	Parabilis Medicines to Raise $745 Million in IPO, Private Offering	MT
09/06	What Bundibugyo Ebola vaccines and treatments are under development	RE

Executive Committee: Regeneron Pharmaceuticals, Inc.

Manager

Positions heldSince

Leonard Schleifer

73 year

Chief Executive Officer	08/01/1988
Founder	08/01/1988
President	08/01/1988

George Yancopoulos

66 year

Chief Tech/Sci/R&D Officer	01/01/2001
Founder	08/01/1988
President	01/01/2001

Andrew Murphy

68 year

Chief Tech/Sci/R&D Officer

01/01/2019

Christopher Fenimore

55 year

Director of Finance/CFO

05/02/2024

Sally A. Paull

Human Resources Officer

01/01/2016

Ned Braunstein

General Counsel

01/01/2009

Joseph LaRosa

67 year

General Counsel	06/09/2011
Corporate Secretary	06/09/2011

Maya Bermingham

General Counsel

01/01/2015

Mark Volpe

Comptroller/Controller/Auditor

01/01/2012

Bob McCowan

Chief Tech/Sci/R&D Officer

Bolanle Akinlade

Chief Tech/Sci/R&D Officer

Ryan Crowe

Investor Relations Contact

01/01/2022

Boaz Hirshberg

Chief Tech/Sci/R&D Officer

01/01/2021

Melissa Lozner

Compliance Officer

01/01/2022

John Calabro

Comptroller/Controller/Auditor

01/01/2005

Leonard Brooks

Treasurer

01/01/2013

Rajesh Ahuja

Chief Operating Officer

01/01/2013

Composition of the Board of Directors: Regeneron Pharmaceuticals, Inc.

Director

CommitteesSince

George Yancopoulos

66 year

Chairman

09/06/2023

Christine Poon

73 year

Executive Committee	01/09/2006
Finance Committee Chair
Governance Committee	06/02/2024
Compensation Committee Chair	16/11/2010
Finance Committee	05/05/2011
Audit Committee	12/02/2024
Nominating Committee	06/02/2024

David Schenkein

68 year

Governance Committee	01/05/2015
Nominating Committee	01/05/2015
Compensation Committee	08/09/2023
Governance Committee Chair
Nominating Committee Chair

N. Coles

65 year

Executive Committee	18/03/2011
Audit Committee	17/02/2017
Compensation Committee	04/04/2025

Arthur Ryan

83 year

Audit Committee	01/01/2003
Governance Committee Chair	01/01/2003

George Sing

76 year

Compensation Committee	08/01/1988
Audit Committee Chair	08/01/1988

Bonnie Bassler

63 year

Governance Committee	12/09/2016
Compensation Committee	30/07/2020

Craig Thompson

73 year

Governance Committee	03/10/2022
Compensation Committee	05/12/2022

Michael Brown

85 year

Governance Committee

01/06/1991

Huda Zoghbi

71 year

Compensation Committee

12/09/2016

Joseph Goldstein

85 year

Governance Committee

14/06/2019

Kathryn Guarini

54 year

Audit Committee

08/09/2023

Leonard Schleifer

73 year

Chairman

09/06/2023

Latest Appointments: Regeneron Pharmaceuticals, Inc.

20/02	AtaiBeckley Inc. Announces Executive Changes, Effective March 9, 2026	CI
21/01	Ocular Therapeutix, Inc. Appoints David W. Robinson As Global Chief Commercial Officer	CI
08/01	Anavex Life Sciences Corp Appoints Dr. Wolfgang Liedtke as Senior Vice President, Global Head of Neurology	CI
28/25/28	Arrivent Biopharma Inc Appoints Merdad Parsey to Its Board of Directors	CI
23/24/23	BridgeBio Pharma, Inc. Announces Executive Changes	CI
01/24/01	Regeneron Pharmaceuticals, Inc. Appoints Jason Pitofsky as Controller, Expects to Occur on February 5, 2024	CI
30/24/30	Regeneron Pharmaceuticals, Inc. Appoints Philip Gregory as Senior Vice President and Head of Regeneron Cell Medicines	CI

More news

Former Officers and Directors: Regeneron Pharmaceuticals, Inc.

Insider

Positions held

SinceUntil

Robert Landry

Director of Finance/CFO	03/10/2013	05/02/2024
Corporate Officer/Principal	09/09/2013	03/10/2013

Marc Tessier-Lavigne

Director/Board Member	21/11/2011	01/09/2023
Independent Dir/Board Member	21/11/2011	01/09/2023

David Weinreich

Private Equity Investor

01/02/2016

01/08/2023

P. Vagelos

Chairman

01/01/1995

09/06/2023

James Cassidy

Corporate Officer/Principal

01/02/2020

01/08/2021

Jay Markowitz

Corporate Officer/Principal

05/01/2017

01/01/2020

Neil Graham

Corporate Officer/Principal

01/01/2009

01/01/2020

Johnathan Lancaster

Chief Tech/Sci/R&D Officer

01/01/2019

Ke Andrew Yuan

Corporate Officer/Principal

01/01/2015

01/01/2019

Manisha A. Narasimhan

Investor Relations Contact

01/09/2011

01/11/2018

Phillip Gutry

Corporate Officer/Principal

01/06/2015

01/10/2018

Jesper Gromada

Corporate Officer/Principal

01/07/2012

01/10/2018

Vesna Tosic

Public Communications Contact

01/09/2018

Charles A. Baker

Director/Board Member	01/02/1989	08/06/2018
Independent Dir/Board Member	01/02/1989	08/06/2018

Robert J. Terifay

Corporate Officer/Principal

26/02/2007

05/01/2018

Peter Powchik

Corporate Officer/Principal

01/10/2006

01/01/2018

Catherine Stehman-Breen

Chief Tech/Sci/R&D Officer	01/01/2015	01/03/2017
General Counsel	01/01/2015	01/03/2017

Pamela A. Trail

Corporate Officer/Principal

01/08/2010

01/03/2017

William J. Sasiela

Corporate Officer/Principal

01/01/2010

01/01/2017

Douglas S. McCorkle

Comptroller/Controller/Auditor

01/05/1998

31/12/2016

Kevin Bailey

Private Equity Investor

01/10/1991

01/01/2016

Robert Alexander Ingram

Director/Board Member	04/04/2014	10/11/2015
Independent Dir/Board Member	11/03/2015	10/11/2015

Murray Goldberg

Chief Administrative Officer	01/03/1995	31/03/2015
Director of Finance/CFO	01/03/1995	03/10/2013
Treasurer	01/03/1995	08/05/2013

Alan Shuldiner

Corporate Officer/Principal

16/10/2014

Eric M. Shooter

Director/Board Member	08/01/1988	30/01/2014
Founder	08/01/1988	30/01/2014
Independent Dir/Board Member	08/01/1988	30/01/2014
Corporate Officer/Principal	08/01/1988	02/09/2009

Hala Mirza

Public Communications Contact

01/01/2014

Julie Clark

Corporate Officer/Principal

01/05/2011

01/10/2012

Carrie Brownstein

Corporate Officer/Principal

01/08/2012

Jim Tripp

Director/Board Member

01/01/2007

01/01/2012

Daniel Brims

Corporate Officer/Principal

31/07/2011

Stuart A. Kolinski

General Counsel	01/09/2000	-
Corporate Secretary	01/09/2000	-

Michael Aberman

Investor Relations Contact

23/03/2010

Randall G. Rupp

Corporate Officer/Principal

01/07/1991

02/04/2008

Beth Levine

Compliance Officer	01/01/2008	01/09/2022
Corporate Officer/Principal	01/01/2008	-

Imogene Dunn

Corporate Officer/Principal

01/01/2003

01/01/2008

Alain Thibault

Chief Tech/Sci/R&D Officer	02/09/2009	14/12/2011
Corporate Officer/Principal	26/02/2007	02/09/2009

Michael Faerm

Corporate Officer/Principal

01/10/2004

Merdad Parsey

Chief Tech/Sci/R&D Officer

01/01/2002

01/01/2004

Kremena Simitchieva

Sales & Marketing

01/01/2004

Hao Zhou

Chief Tech/Sci/R&D Officer

31/12/2001

Fred Middleton

Director/Board Member	01/01/1988	01/01/2001
Director of Finance/CFO	01/01/1988	01/01/2001

William G. Roberts

Chief Tech/Sci/R&D Officer	01/05/1999	-
General Counsel	01/05/1999	-

Denny Lanfear

Corporate Officer/Principal

01/01/1991

01/01/1999

Prasad Inampudi

Corporate Officer/Principal

31/12/1998

Hans-Peter Guler

Corporate Officer/Principal

01/04/1998

Patrice Gilooly

Chief Operating Officer

01/01/1998

Ronald M. Lindsay

Corporate Officer/Principal

01/01/1997

Peter S. DiStefano

Corporate Officer/Principal

01/01/1991

01/01/1997

Gerald Underwood

Corporate Officer/Principal

01/01/1995

Christopher Chapman

Chief Tech/Sci/R&D Officer

01/01/1992

01/01/1994

Stephen Squinto

Corporate Officer/Principal

01/01/1989

01/01/1992

Neil Stahl

Chief Tech/Sci/R&D Officer	01/01/2015	-
Corporate Officer/Principal	01/01/1991	01/01/2015

Alfred G. Gilman

Director/Board Member	08/01/1988	-
Founder	08/01/1988	-
Independent Dir/Board Member	08/01/1988	-
Corporate Officer/Principal	08/01/1988	02/09/2009

Robert Lisicki

Corporate Officer/Principal

Carrie Murray

Corporate Officer/Principal

Justin Holko

Investor Relations Contact

Joseph Ricculli

Public Communications Contact

Sean Stevens

Corporate Officer/Principal

Brendan Classon

Corporate Officer/Principal

Christian Rommel

Chief Tech/Sci/R&D Officer	-	-
Corporate Officer/Principal	-	-

Matt I. Hermann

Corporate Officer/Principal

Charles Poole

Public Communications Contact

Fredric D. Price

Chief Administrative Officer	-	-
Director of Finance/CFO	-	-

Joseph Pantginis

Corporate Officer/Principal

Eric S. Furfine

Corporate Officer/Principal

Paul F. Lubetkin

General Counsel	-	-
Corporate Secretary	-	-

Paul Lin

Corporate Officer/Principal

Peter G. Dworkin

Public Communications Contact

15/12/2009

Alexandra Bowie

Public Communications Contact

Catharine E. Johnson

Corporate Officer/Principal

Steven E. Buchholz

Corporate Officer/Principal

Weng Tao

Corporate Officer/Principal

Avner Ingerman

Corporate Officer/Principal

Janet van Adelsberg

Corporate Officer/Principal

Terence E. Ryan

Corporate Officer/Principal

Potoula Gjidija

Public Communications Contact

Arleen Goldenberg

Public Communications Contact

Sondra Smyrnios

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	33
Female	8

Of which Executive Committee

Male	14
Female	3

Of which Directors

Male	12
Female	1

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Regeneron Pharmaceuticals, Inc. specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Net sales break down by type of revenue as follows: - revenues from collaboration agreements (51.1%): collaboration with Sanofi (80.3% of revenues), Bayer (19.4%) and other (0.3%); - revenues from product sales (30%); - revenues from sales of technology licenses and subcontracted research services (4.9%). At the end of 2025, the group had a portfolio of approximately 45 products in clinical development.

Employees

15,343

Sector

Pharmaceuticals

More about the company